VERSAPEN-K Drug Patent Profile
✉ Email this page to a colleague
When do Versapen-k patents expire, and when can generic versions of Versapen-k launch?
Versapen-k is a drug marketed by Bristol and is included in one NDA.
The generic ingredient in VERSAPEN-K is hetacillin potassium. There are six drug master file entries for this compound. Additional details are available on the hetacillin potassium profile page.
Summary for VERSAPEN-K
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 17 |
Patent Applications: | 337 |
DailyMed Link: | VERSAPEN-K at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for VERSAPEN-K
US Patents and Regulatory Information for VERSAPEN-K
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bristol | VERSAPEN-K | hetacillin potassium | CAPSULE;ORAL | 061396-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Bristol | VERSAPEN-K | hetacillin potassium | CAPSULE;ORAL | 061396-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |